CURE staff

A roundup of some of the most read news and updates in acute myeloid leukemia in 2020 from CURE®.

The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.

The decision was based on data that demonstrated sotorasib induced anticancer activity and achieved a positive benefit-risk profile in patients with locally advanced or metastatic non-small cell lung cancer whose disease harbors a KRAS G12C mutation.

View the full CURE® Educated Patient® Summit on Prostate Cancer here!

Santure was recognized for her compassionate care for patients and their families; also during virtual ceremony, Elizabeth Farrat named 2020 The Finest Hour award winner.

Charles J. Ryan, M.D., internationally recognized for his research on prostate cancer, discusses risk factors, treatments and racial disparities associated with the disease.

A roundup of the latest news and updates for patients with metastatic breast cancer from CURE®.

A roundup of the latest news and updates for patients with prostate cancer from CURE®.

Join us for our Chronic Lymphocytic Leukemia webinar where experts discuss CLL information highly relevant to patients, caregivers, advocates and discuss patient questions.

On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.

On social media, CURE® recently asked its readers to share how they pamper and treat themselves during or after their cancer treatment. Here, we share some of their responses.

On social media, CURE® recently asked its readers to share how they cope with anxiety leading up to their next scans. Here, we share some of their responses.

The FDA’s fast track designation for BST-236 to treat adults aged 75 years or older with acute myeloid leukemia, or who have comorbidities that prevent the use of intensive induction chemotherapy, may open the doors to an accelerated approval.

On social media, CURE® recently asked its readers to share the advice they would give someone looking to help a friend or loved one with cancer. Here, we share some of their responses.

A roundup of the latest news and updates for patients with ovarian cancer from CURE®.

The Food and Drug Administration has had a busy summer, approving new agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

Leading experts in the CLL landscape discuss the latest treatment options for patients and answer questions from the CURE audience.

We asked and you answered! Here's what CURE readers had to say about whether or not their care teams helped with crafting a survivorship plan.

Here is a list of the recent trial initiations that occurred within the cancer space in June.

In partnership with CURE®, Susan G. Komen Greater New York City hosts its 4th Annual Patient Navigation Town Hall "Empowering and Mobilizing Our Patient Navigation Workforce". Oncologists, community health workers and patient navigators will get together on June 23rd, via webinar, to discuss the impact of the COVID-19 pandemic on the cancer landscape and how professionals and patients can navigate the fallout moving forward.

4 Chronic Lymphocytic Leukemia experts hosted a webinar, in partnership with CURE, addressing the latest and most important topics for patients with CLL.

CURE hosted its third webinar on all the latest topics and trends for patients with lung cancer.

Join us online for an informative lung cancer webinar on Thursday, June 18, 2020, from 7 - 8 p.m. PT.

Join us online for an informative chronic lymphocytic leukemia webinar on Wednesday, June 17, 2020, at 7 - 8 p.m. ET.

To commemorate National Cancer Survivors Day on June 7, CURE® invited its readers to share their encouraging stories of survival.

CURE hosted its second webinar that will focus on all the latest topics and trends for patients with lung cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in May.

CURE hosted its first webinar, focused on all the latest topics and trends for patients with lung cancer.

The Food and Drug Administration continues to approve cancer therapies amid the COVID-19 pandemic. Here are five approvals that patients with cancer may have missed.

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Dr. Farukh Awan addressed concerns about the possibility of developing COVID-19 or any infection after a stem cell transplant to treat a blood cancer.